7.785
price up icon0.39%   0.055
 
loading
Schlusskurs vom Vortag:
$7.73
Offen:
$7.8
24-Stunden-Volumen:
78,691
Relative Volume:
0.29
Marktkapitalisierung:
$278.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.11%
1M Leistung:
+31.97%
6M Leistung:
+84.76%
1J Leistung:
-67.12%
1-Tages-Spanne:
Value
$7.744
$7.87
1-Wochen-Bereich:
Value
$7.245
$8.15
52-Wochen-Spanne:
Value
$2.88
$24.00

Bioage Labs Inc Stock (BIOA) Company Profile

Name
Firmenname
Bioage Labs Inc
Name
Telefon
510-806-1445
Name
Adresse
5885 HOLLIS STREET, EMERYVILLE
Name
Mitarbeiter
64
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
BIOA's Discussions on Twitter

Vergleichen Sie BIOA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
BIOA
Bioage Labs Inc
7.78 277.12M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.02 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.43 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.245 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.09 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
448.03 19.53B 3.08B 1.24B 1.07B 25.61

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-22 Hochstufung Citigroup Neutral → Buy
2025-02-28 Eingeleitet William Blair Mkt Perform
2024-12-10 Herabstufung Morgan Stanley Overweight → Underweight
2024-12-09 Herabstufung Citigroup Buy → Neutral
2024-12-09 Herabstufung Jefferies Buy → Hold
2024-10-21 Eingeleitet Citigroup Buy
2024-10-21 Eingeleitet Jefferies Buy
2024-10-21 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten

pulisher
06:52 AM

Does BioAge Labs Inc. show high probability of reboundJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com

06:52 AM
pulisher
06:01 AM

Sector ETF performance correlation with BioAge Labs Inc.Earnings Overview Report & Risk Controlled Daily Trade Plans - newser.com

06:01 AM
pulisher
05:24 AM

How BioAge Labs Inc. stock compares to growth peersDollar Strength & Weekly Top Performers Watchlists - newser.com

05:24 AM
pulisher
04:44 AM

Analyzing drawdowns of BioAge Labs Inc. with statistical toolsJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com

04:44 AM
pulisher
02:39 AM

Can BioAge Labs Inc. stock resist sector downturnsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com

02:39 AM
pulisher
01:32 AM

Order flow analysis tools used on BioAge Labs Inc.CEO Change & Weekly Market Pulse Updates - newser.com

01:32 AM
pulisher
12:35 PM

Published on: 2025-10-30 23:35:20 - newser.com

12:35 PM
pulisher
12:24 PM

Using data models to predict BioAge Labs Inc. stock movementBuy Signal & Weekly Stock Performance Updates - newser.com

12:24 PM
pulisher
Oct 30, 2025

BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Update - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Why BioAge Labs Inc. stock could be next big winnerBull Run & Verified Stock Trade Ideas - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What candlestick patterns are forming on BioAge Labs Inc.Market Weekly Review & AI Driven Price Predictions - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is BioAge Labs Inc. stock attractive for long term wealth building2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Citigroup Maintains BioAge Labs (BIOA) Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Bioage Labs (BIOA) Receives Raised Price Target from Citigroup | - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026? - AOL.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is BioAge Labs Inc. (Y7G) stock supported by free cash flow2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Analyzing BioAge Labs Inc. with risk reward ratio chartsWeekly Profit Report & Fast Moving Stock Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why BioAge Labs Inc. (Y7G) stock stays undervaluedWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

BioAge Labs (BIOA) Price Target Increased by 71.43% to 8.16 - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Positive Week for BioAge Labs, Inc. (NASDAQ:BIOA) Institutional Investors Who Lost 68% Over the Past Year - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

How strong is BioAge Labs Inc. (Y7G) stock earnings growthJuly 2025 Technicals & Technical Pattern Alert System - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Automated trading signals detected on BioAge Labs Inc.July 2025 Levels & Weekly Return Optimization Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will BioAge Labs Inc. stock benefit from infrastructure spendingJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 22:26:35 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to Value Scintilla Commercial Credit Limited Stock Using DCF AnalysisRSI Overbought/Oversold & Low Entry Investment Ideas - earlytimes.in

Oct 27, 2025
pulisher
Oct 27, 2025

Is BioAge Labs Inc a good long term investmentSwing Trading Watchlist & Free Grow Wealth With Picks - earlytimes.in

Oct 27, 2025
pulisher
Oct 26, 2025

BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher? - sharewise.com

Oct 26, 2025

Finanzdaten der Bioage Labs Inc-Aktie (BIOA)

Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.62
price up icon 5.78%
drug_manufacturers_specialty_generic RDY
$13.32
price down icon 1.00%
$22.70
price up icon 0.55%
$10.38
price up icon 0.25%
$140.26
price up icon 1.07%
$448.03
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):